News

Kris Hans shares how Biosenta is tackling the antimicrobial health crisis at the source, and why this work matters now more than ever.

Biosenta Inc. announces licensing agreement

Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta’s Tri-Filler® technology and get fee of C$200,000 and royalties

UoC professor taking about a solution fighting a drug-resistant fungus that has become a big issue for hospitals in the U.S. and Canada.

Biosenta Inc. announces further advances in research and development of the Tri-Filler™ particle.

Biosenta announces entering into of agreement to terminate joint venture

Biosenta Inc. announces that it has ceased negotiations with Voran Group Ventures Ltd.

Chelsey Reschke is one of 47 Canadians attending the G20 Young Entrepreneurs’ Alliance summit in Hamburg from Oct. 27 to 28.

Biosenta Inc. has signed an MOU with Voran Group Ventures Ltd. for the commercialization of Biosenta’s Tri-Filler® antimicrobial products.

University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry

Biosenta Inc. announces that it has entered into an agreement to settle $1,015,088.47 of debt through issuance of 3,625,315 common shares.

Biosenta is launching a dual-action, broad-spectrum anti-microbial disinfectant to combat COVID-19 in North America.